TLOG (TetraLogic Pharmaceuticals) Enterprise Value: $0.00 Mil (As of Jul. 07, 2026) ***


What is TetraLogic Pharmaceuticals Enterprise Value?

TetraLogic Pharmaceuticals TLOG Enterprise Value is $0.00 Mil as of Jul. 07, 2026.

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, TetraLogic Pharmaceuticals's Enterprise Value is $0.00 Mil. TetraLogic Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Sep. 2016 was $-36.24 Mil. Therefore, TetraLogic Pharmaceuticals's EV-to-EBIT ratio for today is 0.00.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, TetraLogic Pharmaceuticals's Enterprise Value is $0.00 Mil. TetraLogic Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2016 was $-36.09 Mil. Therefore, TetraLogic Pharmaceuticals's EV-to-EBITDA ratio for today is 0.00.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, TetraLogic Pharmaceuticals's Enterprise Value is $0.00 Mil. TetraLogic Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2016 was $0.00 Mil. Therefore, TetraLogic Pharmaceuticals's EV-to-Revenue ratio for today is .

EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations. As of today, TetraLogic Pharmaceuticals's Enterprise Value is $0.00 Mil. TetraLogic Pharmaceuticals's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2016 was $-23.88 Mil. Therefore, TetraLogic Pharmaceuticals's EV-to-OCF ratio for today is 0.00.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, TetraLogic Pharmaceuticals's Enterprise Value is $0.00 Mil. TetraLogic Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2016 was $-23.88 Mil. Therefore, TetraLogic Pharmaceuticals's EV-to-FCF ratio for today is 0.00.

*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.


TetraLogic Pharmaceuticals  (OTCPK:TLOG) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

TetraLogic Pharmaceuticals's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-36.24
=0.00

TetraLogic Pharmaceuticals's current Enterprise Value is $0.00 Mil.
TetraLogic Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-36.24 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

TetraLogic Pharmaceuticals's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=0.000/-36.086
=0.00

TetraLogic Pharmaceuticals's current Enterprise Value is $0.00 Mil.
TetraLogic Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-36.09 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

TetraLogic Pharmaceuticals's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.000/0
=

TetraLogic Pharmaceuticals's current Enterprise Value is $0.00 Mil.
TetraLogic Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

4. EV-to-OCF is calculated as Enterprise Value divided by its Cash Flow from Operations.

TetraLogic Pharmaceuticals's EV-to-OCF for today is:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=0.000/-23.881
=0.00

TetraLogic Pharmaceuticals's current Enterprise Value is $0.00 Mil.
TetraLogic Pharmaceuticals's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.88 Mil.

5. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

TetraLogic Pharmaceuticals's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.000/-23.882
=0.00

TetraLogic Pharmaceuticals's current Enterprise Value is $0.00 Mil.
TetraLogic Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TetraLogic Pharmaceuticals Enterprise Value Related Terms


TetraLogic Pharmaceuticals Enterprise Value Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Enterprise Value Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Enterprise Value
0.00 0.00 156.20 81.26 50.72

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.10 50.72 18.94 28.83 28.83

TLOG vs ARGSQ, GTHR, SOAN: Enterprise Value Comparison

For the Biotechnology subindustry, TetraLogic Pharmaceuticals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TetraLogic Pharmaceuticals Enterprise Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TetraLogic Pharmaceuticals's Enterprise Value distribution charts can be found below:

* The bar in red indicates where TetraLogic Pharmaceuticals's Enterprise Value falls into.



TetraLogic Pharmaceuticals Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

TetraLogic Pharmaceuticals's Enterprise Value for the fiscal year that ended in Dec. 2015 is calculated as

TetraLogic Pharmaceuticals's Enterprise Value for the quarter that ended in Sep. 2016 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Enterprise Value →
What does a Enterprise Value of $0.00 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Enterprise Value of $0.00 Mil as of Jul. 07, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Enterprise Value too high?
TetraLogic Pharmaceuticals' current Enterprise Value is $0.00 Mil.
How does TetraLogic Pharmaceuticals' Enterprise Value compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Enterprise Value of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Enterprise Value is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Enterprise Value of $0.00 Mil. The current Enterprise Value is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Enterprise Value is $0.00 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.